Randomized trial of peginterferon alfa-2b and ribavirin for 48 or 72 weeks in patients with hepatitis C virus genotype 1 and slow virologic response.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples